scholarly journals 1365TiP A phase I/II, open-label study of BBT-176, a triple mutation targeting EGFR TKI, in patients with NSCLC who progressed after prior EGFR TKI therapy

2021 ◽  
Vol 32 ◽  
pp. S1035
Author(s):  
S.M. Lim ◽  
D-W. Kim ◽  
J.E. Jung ◽  
G. Lee ◽  
J-H. Ryou ◽  
...  
Keyword(s):  
Phase I ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Triple Mutation ◽  
Egfr Tki

scholarly journals Interim analysis from a phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC

2019 ◽  
Vol 30 ◽  
pp. ix161-ix162
Author(s):  
F. De Marinis ◽  
K.K. Laktionov ◽  
A. Poltoratskiy ◽  
I. Egorova ◽  
M. Hochmair ◽  
...  
Keyword(s):  
Interim Analysis ◽  
Egfr Mutation ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Phase Iiib ◽  
Egfr Tki

A phase I open-label study investigating the disposition of [14C]-cabazitaxel in patients with advanced solid tumors

2015 ◽  
Vol 26 (3) ◽  
pp. 350-358 ◽  
Author(s):  
Laurence Ridoux ◽  
Dorothée R. Sémiond ◽  
Carine Vincent ◽  
Hélène Fontaine ◽  
Christine Mauriac ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

A phase I, open-label study of the safety, tolerability and pharmacokinetics of lapatinib (GW572016) in combination with letrozole in cancer patients

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 3001-3001 ◽  
Author(s):  
Q. Chu ◽  
L. Goldstein ◽  
N. Murray ◽  
E. Rowinsky ◽  
M. Cianfrocca ◽  
...  
Keyword(s):  
Phase I ◽  
Cancer Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals Ren Shen Yangrong Tang for Fatigue in Cancer Survivors: A Phase I/II Open-Label Study

2015 ◽  
Vol 21 (5) ◽  
pp. 281-287 ◽  
Author(s):  
Yichen Xu ◽  
Yanzhi Chen ◽  
Pingping Li ◽  
Xin Shelley Wang
Keyword(s):  
Phase I ◽  
Cancer Survivors ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer

2010 ◽  
Vol 67 (4) ◽  
pp. 751-764 ◽  
Author(s):  
Anthony W. Tolcher ◽  
Leonard J. Appleman ◽  
Geoffrey I. Shapiro ◽  
Alain C. Mita ◽  
Frank Cihon ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Cardiovascular Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2

2018 ◽  
Vol 118 (3) ◽  
pp. 344-352 ◽  
Author(s):  
Rastislav Bahleda ◽  
Andrea Varga ◽  
Yann Bergé ◽  
Jean-Charles Soria ◽  
David Schnell ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumours ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document